Macro & Rates114d ago
Targeted Pharma Levies Trigger Credit Spread Scrutiny, Sector Volatility
President Trump's selective pharmaceutical levies, exempting cooperating firms, introduce a nuanced risk profile for branded drug manufacturers, prompting re-evaluation of sector-specific credit and equity exposures without broad market contagion.